共 50 条
- [31] CLINICAL USE OF IN-111 LABELED WHITE CELLS - AN ANALYSIS OF 312 CASES BRITISH JOURNAL OF RADIOLOGY, 1980, 53 (633): : 926 - 926
- [33] STUDIES ON THE METABOLIC-FATE OF IN-111 LABELED ANTIBODIES NUCLEAR MEDICINE AND BIOLOGY, 1989, 16 (08): : 839 - 845
- [34] Y-90 LABELED ANTIBODIES - BIOLOGICAL DISTRIBUTION AND POST-INJECTION MANIPULATION OF THE YTTRIUM ION CANCER DRUG DELIVERY, 1985, 2 (03): : 238 - 238
- [35] COMPARATIVE PHARMACOKINETICS OF IN-111 AND Y-90 B72.3 IN PATIENTS FOLLOWING SINGLE DOSE INTRAVENOUS ADMINISTRATION ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1992, 5 (03): : 285 - 294
- [37] Radioimmunotherapy of glioblastoma by using I-131 and Y-90 labeled antitenascin Monoclonal Antibodies. RADIOACTIVE ISOTOPES IN CLINICAL MEDICINE AND RESEARCH XXIII, 1999, : 59 - 63
- [39] QUALITY CONTROL OF Ga-68, In-111, Y-90 AND Lu-177 LABELED DOTA-DERIVATISED PEPTIDE ANALOGS USING A COMBINATION OF HPLC AND TLC JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S290 - S290
- [40] IMPROVED TUMOR-LOCALIZATION USING IN-111 LABELED ANTIBODIES BRITISH MEDICAL JOURNAL, 1983, 287 (6386): : 167 - 170